US OptionsDetailed Quotes
PFE240823C28000
- 0.88
- +0.11+14.29%
15min DelayClose Aug 23 16:00 ET
0.99High0.68Low
0.79Open0.77Pre Close538 Volume1.35K Open Interest28.00Strike Price43.65KTurnover0.00%IV-0.07%PremiumAug 23, 2024Expiry Date0.90Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma32.47Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Pfizer Stock Discussion
Sign in to post a comment
$GeoVax Labs (GOVX.US)$ Their COVID vaccine also protects against smallpox and mpox. And their COVID vaccine works more effectively than $Moderna (MRNA.US)$ and $Pfizer (PFE.US)$.
"GeoVax’s COVID-19 vaccine candidates, which can induce strong antibody and T cell responses against the variants of the SARS-CoV-2 virus, also offers the possibility of protection against Mpox and smallpox diseases, further differentiating GEO-CM04S1 as compared to current mRNA-based COVID-19 vaccines. Such attributes ma...
"GeoVax’s COVID-19 vaccine candidates, which can induce strong antibody and T cell responses against the variants of the SARS-CoV-2 virus, also offers the possibility of protection against Mpox and smallpox diseases, further differentiating GEO-CM04S1 as compared to current mRNA-based COVID-19 vaccines. Such attributes ma...
6
2
$Pfizer (PFE.US)$
Vaccines will be available in the coming days, drugmakers say
The Food and Drug Administration on Thursday gave Pfizer Inc. and Moderna Inc. approval for updated COVID-19 vaccines, as a summer wave of the virus is still rolling across the country.
Pfizer and partner BioNTech's (BNTX) Comirnaty vaccine and Moderna's Spikevax were approved for people 12 years old and up, the FDA said, while versions of the shots for children between 6 months and 11 years old were granted emergency...
Vaccines will be available in the coming days, drugmakers say
The Food and Drug Administration on Thursday gave Pfizer Inc. and Moderna Inc. approval for updated COVID-19 vaccines, as a summer wave of the virus is still rolling across the country.
Pfizer and partner BioNTech's (BNTX) Comirnaty vaccine and Moderna's Spikevax were approved for people 12 years old and up, the FDA said, while versions of the shots for children between 6 months and 11 years old were granted emergency...
1
$Pfizer (PFE.US)$
It is possible to see a three white soldiers pattern tomorrow. The stock is on the up trend.
It is possible to see a three white soldiers pattern tomorrow. The stock is on the up trend.
4
$Pfizer (PFE.US)$ better to buy now before mpox spreads worldwide and everyone takes vaccines again
5
1
$Pfizer (PFE.US)$
The chart shows a hammer last Friday. The stock is likely to reach the bottom and it’s rebounding from low. Next hit point is 29.18.
The chart shows a hammer last Friday. The stock is likely to reach the bottom and it’s rebounding from low. Next hit point is 29.18.
2
2
$Pfizer (PFE.US)$
According to the Futubull Financial News APP, the US Food and Drug Administration (FDA) is preparing to approve an updated version of the Covid vaccine targeted at the current epidemic virus strain as early as this week to deal with the largest summer epidemic in the United States in nearly two years. It is reported that the FDA will approve the updated mRNA vaccine targeting the KP.2 virus strain developed by Pfizer (PFE.US)/BioNTech (BNTX.US) and Moderna (MRNA.US). It is not y...
According to the Futubull Financial News APP, the US Food and Drug Administration (FDA) is preparing to approve an updated version of the Covid vaccine targeted at the current epidemic virus strain as early as this week to deal with the largest summer epidemic in the United States in nearly two years. It is reported that the FDA will approve the updated mRNA vaccine targeting the KP.2 virus strain developed by Pfizer (PFE.US)/BioNTech (BNTX.US) and Moderna (MRNA.US). It is not y...
3
$Pfizer (PFE.US)$
I added some shares at 28.21 and 28.15 last night to dca.
I added some shares at 28.21 and 28.15 last night to dca.
2
$Pfizer (PFE.US)$ I want calls for eod but might not be able to break this drop
1
No comment yet
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.